Postnatal Mental Health: Recognising the Signs and Taking Care
An article by clinical psychologist Ana Beatriz Sousa explaining the importance of mental health after giving birth.
Read more
From time to time, obstetricians, transplant teams and, in particular, people who work in cord blood banks come across claims based on misinformation and pure speculation. The Cord Blood Association recently asked its members to identify the main myths that less well-informed people hold about cord blood. From that long list, 8 relevant points stand out:
Collecting cord blood can affect the baby's health.
The blood is collected from the umbilical cord and the placenta after the baby is born and the umbilical cord has been cut. No blood sample is taken from the baby. Collecting cord blood does not interfere with labour or birth. Nor does it put the health of the baby or the mother at risk.
Umbilical cord blood stored in a private bank can be used by any family member.
Umbilical cord blood samples stored in private banks cannot be used to treat just any family member.
Cord blood carries genetic markers, called HLA (human leucocyte antigens), which need to match between donor and recipient. The probability of one sibling being a full match for another (siblings with the same parents) is around 25%, and there is around a 50% chance of sharing half of the HLA with another sibling. Other family members are even less likely to be a match for each other.
Cord blood treatments are merely experimental.
Cord blood is a source of stem cells for patients who need a transplant. Cord blood is used to treat more than 80 diseases, including blood cancers, genetic disorders, bone marrow failure and immune diseases.
In other areas, cord blood therapies have been studied for treating heart disease, nervous system disorders, bone and joint diseases, metabolic diseases and, above all, in regenerative medicine.
The value of cord blood therapies will depend on how clinical trials progress and on their results.
As long as I store my first child's blood sample, I don't need to store my second child's.
The reasons for storing a sample of your first child's umbilical cord blood are exactly the same as for storing your second child's, because the probability of a match between siblings is 25%.
If I decide to store the cord blood sample, there's no point in storing the cord tissue.
Every year, new uses are discovered not only for cord blood but also for cord tissue. Both cord blood and other perinatal cells, including cord tissue, hold great promise for treating many diseases that currently have no cure. Expectant parents should therefore ask private banks how cord tissue is stored and what its potential future uses are, so that they can make an informed, well-grounded decision.
Umbilical cord blood is biological waste with no clinical value.
A baby's umbilical cord blood contains stem cells which, when transplanted, can restore bone marrow function and consequently rebuild the immune system.
Infusing these cells can also help treat leukaemias, lymphomas and other conditions, such as genetic disorders, bone marrow failure or immunodeficiencies. Since the first transplant was performed in 1988, more than 40,000 patients have benefited from umbilical cord blood cells to treat serious diseases.
Expectant parents have until the day of the birth to decide whether to collect their baby's umbilical cord blood.
The decision about collecting cord blood should be made well in advance. Expectant parents should discuss with their obstetrician or another qualified health professional whether to store their baby's umbilical cord blood.
When you choose delayed cord clamping, there isn't much blood or many cells left to store.
The scientific community, particularly in the USA, currently recommends clamping the umbilical cord 30 to 60 seconds after birth. Delayed cord clamping is believed to benefit the baby during the first six months of life. However, delayed clamping can reduce the number of stem cells circulating in the umbilical cord, and may even make collection impossible.
It is worth remembering that when the sample is intended for a sibling with a condition such as leukaemia or similar, delayed cord clamping is not advised.
Above all, expectant parents should discuss their options for delayed cord clamping with their obstetrician or midwife.
Article written by the BebéVida Team, based on the list published by the Cord Blood Association
Comments (0)
Be the first to comment on this article.